InsiderClue
Stocks · Health care · Surgical & Medical Instruments & Apparatus

NEUROONE MEDICAL TECHNOLOGIES Corp

NMTC Clue Score60
United States Fiscal year ends September CIK 0001500198
$1.12 +3.70% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.12 −72.88% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 18 Sep 2017. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−0.0Net income−0.0Fiscal year 2017Operating income−3.1Net income−5.1Fiscal year 2019Operating income−5.8Net income−6.8Fiscal year 2020Operating income−4.9Net income−13.6Fiscal year 2021Revenue0.2Operating income−10.2Net income−9.9EPS, diluted−0.93Fiscal year 2022Revenue0.2 −3.9%Operating income−10.0Net income−10.0EPS, diluted−0.63Fiscal year 2023Revenue2.0 +1,040.7%Operating income−12.0Net income−11.9EPS, diluted−0.65Fiscal year 2024Revenue3.5 +76.9%Operating income−11.9Net income−12.3EPS, diluted−0.46Fiscal year 2025Revenue9.1 +163.5%Operating income−4.2Net income−3.6EPS, diluted−0.09
FY2016FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 n/a n/a n/a 0.2 0.2 2.0 3.5 9.1
Growth −3.9% +1,040.7% +76.9% +163.5%
Operating income −0.0 −3.1 −5.8 −4.9 −10.2 −10.0 −12.0 −11.9 −4.2
Net income −0.0 −5.1 −6.8 −13.6 −9.9 −10.0 −11.9 −12.3 −3.6
Growth
EPS, diluted n/a n/a n/a n/a −0.93 −0.63 −0.65 −0.46 −0.09

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2019Fiscal year 2020Fiscal year 2021Gross margin−54.9%Operating margin−5,735.9%Net margin−5,584.3%Free cash flow margin−4,866.7%Fiscal year 2022Gross margin−41.4%Operating margin−5,860.2%Net margin−5,842.0%Free cash flow margin−4,553.8%Fiscal year 2023Gross margin23.4%Operating margin−612.3%Net margin−607.4%Free cash flow margin−679.7%Fiscal year 2024Gross margin31.3%Operating margin−344.3%Net margin−356.7%Free cash flow margin−322.4%Fiscal year 2025Gross margin56.5%Operating margin−46.5%Net margin−39.6%Free cash flow margin−32.1%
FY2016FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a n/a n/a n/a −54.9% −41.4% 23.4% 31.3% 56.5%
Operating margin n/a n/a n/a n/a −5,735.9% −5,860.2% −612.3% −344.3% −46.5%
Net margin n/a n/a n/a n/a −5,584.3% −5,842.0% −607.4% −356.7% −39.6%
Free cash flow margin n/a n/a n/a n/a −4,866.7% −4,553.8% −679.7% −322.4% −32.1%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−0.0Fiscal year 2017Operating cash flow−2.1Fiscal year 2019Operating cash flow−5.4Capital expenditure−0.1Free cash flow−5.5Fiscal year 2020Operating cash flow−3.4Capital expenditure−0.1Free cash flow−3.5Fiscal year 2021Operating cash flow−8.6Capital expenditure−0.1Free cash flow−8.7Fiscal year 2022Operating cash flow−7.5Capital expenditure−0.3Free cash flow−7.8Fiscal year 2023Operating cash flow−12.9Capital expenditure−0.4Free cash flow−13.3Fiscal year 2024Operating cash flow−11.0Capital expenditure−0.1Free cash flow−11.1Fiscal year 2025Operating cash flow−2.8Capital expenditure−0.1Free cash flow−2.9
FY2016FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −0.0 −2.1 −5.4 −3.4 −8.6 −7.5 −12.9 −11.0 −2.8
Capital expenditure n/a n/a −0.1 −0.1 −0.1 −0.3 −0.4 −0.1 −0.1
Free cash flow n/a n/a −5.5 −3.5 −8.7 −7.8 −13.3 −11.1 −2.9
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2016Cash0.5Shareholders’ equity−0.3Fiscal year 2017Cash0.0Shareholders’ equity−5.0Fiscal year 2019Cash0.3Shareholders’ equity−1.2Fiscal year 2020Cash4.0Shareholders’ equity2.1Fiscal year 2021Cash6.9Shareholders’ equity6.6Fiscal year 2022Cash8.2Shareholders’ equity9.6Fiscal year 2023Cash5.3Shareholders’ equity6.2Fiscal year 2024Cash1.5Shareholders’ equity0.8Fiscal year 2025Cash6.6Shareholders’ equity7.1
FY2016FY2017FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 0.5 0.0 0.3 4.0 6.9 8.2 5.3 1.5 6.6
Shareholders’ equity −0.3 −5.0 −1.2 2.1 6.6 9.6 6.2 0.8 7.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending September, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2019 30 Sep 2019 FY2020 30 Sep 2020 FY2021 30 Sep 2021 FY2022 30 Sep 2022 FY2023 30 Sep 2023 FY2024 30 Sep 2024 FY2025† 30 Sep 2025
Revenue and profit
0.0 n/a n/a n/a 0.2 0.2 2.0 3.5 9.1
Growth −3.9% +1,040.7% +76.9% +163.5%
n/a n/a n/a n/a 0.3 0.2 1.5 2.4 4.0
n/a n/a n/a n/a −0.1 −0.1 0.5 1.1 5.1
Growth +136.5% +376.2%
n/a 0.7 1.5 2.1 3.9 4.9 6.9 5.1 5.0
0.0 2.3 4.3 4.8 6.3 7.0 6.9 7.9 7.4
−0.0 −3.1 −5.8 −4.9 −10.2 −10.0 −12.0 −11.9 −4.2
Growth
−0.0 n/a n/a −2.0 n/a −10.0 −11.9 −12.3 −3.6
0.0 n/a n/a n/a −0.3 n/a n/a n/a n/a
−0.0 −5.1 −6.8 −13.6 −9.9 −10.0 −11.9 −12.3 −3.6
Growth
Per share
n/a n/a n/a n/a −0.93 −0.63 −0.65 −0.46 −0.09
n/a n/a n/a n/a −0.93 −0.63 −0.65 −0.46 −0.09
Growth
n/a n/a n/a n/a 10.7 16.0 18.1 26.8 40.2
n/a n/a n/a n/a 10.7 16.0 18.1 26.8 40.2
Growth +49.6% +13.3% +47.7% +50.0%

† The diluted share count jumps at 2025, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 9 of 9 years on file.